Hanmi Pharm owns 12 improved new drugs, ranking the top, followed by Chong Kun Dang with 10 products
The number of new improved drugs developed by domestic pharmaceutical companies from 1993 when they first begun to actively develop them was 107 products of 27 companies, averaging 4 per company.
According to the data surveyed and collected by the Korea Drug Research Association, Hanmi Pharm own...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
